Abstract

Intertrochanteric femoral fractures are of great interest all around the world. They are the most often performed fracture type, and the high expense of treatment required following injury has made them a critical health resource concern. A higher predisposition towards Intertrochanteric fracture is observed in females than males due to osteoporosis A substantial demand is placed on the implanted hardware, as the subtrochanteric region of the femur experiences mechanical forces several multiples of the patient’s weight.The primary objective of this study was to evaluate the functional result of inter- and sub-trochanteric femur fractures treated with Proximal Femur Nail Antirotation-II. To improve the rotational stability of the proximal fracture fragment, the trochanteric fixation nail (TFN) was designed. To lessen bone tension at the isthmus, the diameter of the distal tip of the nail was lowered. The research was carried out in the Department of Orthopaedics, Krishna Institute of Medical Sciences, Karad. The research was carried out between June 2019 and June 2021. The Department of Ethics of Krishna Institute of Medical Sciences, Deemed to be University Karad, granted the ethics committee permission. There were 60 individuals in the research who had intertrochanteric and subtrochanteric femur fractures. After receiving informed written consent in the specified way, all participants were included. In summary, PFN A-II is a stable, biomechanically acceptable implant with a clear advantage over other implants for treating stable and unstable intertrochanteric fractures, particularly those in the elderly, and linked with osteoporotic bone. The benefits of the PFN A-II are noticeable with the right surgical approach, with a bare minimum complication rate.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call